Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Public ClinicalTrials.gov record NCT06988618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT06988618
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2025
- Primary completion
- Nov 29, 2027
- Completion
- Nov 29, 2027
- Last update posted
- May 31, 2026
2025 – 2027
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site # 8893 | Birmingham | Alabama | 35244 | Not yet recruiting |
| Galderma Investigational Site # 7077 | Phoenix | Arizona | 85006-2754 | Not yet recruiting |
| Galderma Investigational Site # 7060 | Phoenix | Arizona | 85008-3884 | Not yet recruiting |
| Galderma Investigational Site # 7067 | Tucson | Arizona | 85718 | Not yet recruiting |
| Galderma Investigational Site # 7074 | Corona | California | 92882 | Not yet recruiting |
| Galderma Investigational Site # 6836 | Fountain Valley | California | 92708-3701 | Recruiting |
| Galderma Investigational Site # 8224 | Fremont | California | 94538-1603 | Not yet recruiting |
| Galderma Investigational Site # 7064 | Santa Monica | California | 90404-2216 | Not yet recruiting |
| Galderma Investigational Site # 7061 | Castle Rock | Colorado | 80109-8034 | Not yet recruiting |
| Galderma Investigational Site # 7059 | Fairfield | Connecticut | 06824 | Not yet recruiting |
| Galderma Investigational Site # 7087 | Coral Gables | Florida | 33134 | Not yet recruiting |
| Galderma Investigational Site # 7063 | Cutler Bay | Florida | 33157 | Not yet recruiting |
| Galderma Investigational Site # 7078 | Miami | Florida | 33173 | Not yet recruiting |
| Galderma Investigational Site # 7070 | North Miami Beach | Florida | 33162-4708 | Not yet recruiting |
| Galderma Investigational Site # 7091 | Tampa | Florida | 33615-4537 | Not yet recruiting |
| Galderma Investigational Site # 7058 | Chicago | Illinois | 60641 | Not yet recruiting |
| Galderma Investigational Site # 8142 | Indianapolis | Indiana | 46250-2041 | Not yet recruiting |
| Galderma Investigational Site # 8012 | Glendale | Maryland | 20769-9182 | Not yet recruiting |
| Galderma Investigational Site # 7068 | Rockville | Maryland | 20850-6243 | Not yet recruiting |
| Galderma Investigational Site # 7065 | Brighton | Massachusetts | 02135 | Not yet recruiting |
| Galderma Investigational Site # 7066 | Auburn Hills | Michigan | 48326-3396 | Not yet recruiting |
| Galderma Investigational Site # 7071 | Caledonia | Michigan | 49316-7478 | Not yet recruiting |
| Galderma Investigational Site # 7072 | Troy | Michigan | 48084-5260 | Not yet recruiting |
| Galderma Investigational Site # 7053 | Waterford | Michigan | 48328 | Not yet recruiting |
| Galderma Investigational Site # 7057 | Lee's Summit | Missouri | 64064 | Not yet recruiting |
| Galderma Investigational Site # 7076 | St Louis | Missouri | 63141-7068 | Not yet recruiting |
| Galderma Investigational Site # 7055 | Portsmouth | New Hampshire | 03801-7156 | Recruiting |
| Galderma Investigational Site # 7080 | Auburn | New York | 13021 | Not yet recruiting |
| Galderma Investigational Site # 7052 | East Syracuse | New York | 13057 | Not yet recruiting |
| Galderma Investigational Site # 8282 | Mount Kisco | New York | 10549-3035 | Not yet recruiting |
| Galderma Investigational Site # 7056 | New York | New York | 10012-1354 | Not yet recruiting |
| Galderma Investigational Site # 7051 | New York | New York | 10023 | Not yet recruiting |
| Galderma Investigational Site # 7081 | Dayton | Ohio | 45414-2799 | Not yet recruiting |
| Galderma Investigational Site # 8559 | Philadelphia | Pennsylvania | 19103-4738 | Not yet recruiting |
| Galderma Investigational Site # 8238 | Dallas | Texas | 75230-5808 | Not yet recruiting |
| Galderma Investigational Site # 7062 | Edinburg | Texas | 78539-4660 | Not yet recruiting |
| Galderma Investigational Site # 7088 | Grapevine | Texas | 76051 | Not yet recruiting |
| Galderma Investigational Site # 7069 | Sugar Land | Texas | 77478-3842 | Not yet recruiting |
| Galderma Investigational Site # 7079 | Vienna | Virginia | 22182 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06988618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06988618 live on ClinicalTrials.gov.